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Salmonella infections continue to cause substantial morbidity and mortality throughout the world. However,
recent discoveries and new paradigms promise to lead to novel strategies to diagnose, treat, and prevent
Salmonella infections. This review provides an update of the Salmonella field based on oral presentations given
at the recent 3rd ASM Conference on Salmonella: Biology, Pathogenesis and Prevention.
It was six men of Indostan
To learning much inclined,
Who went to see the Elephant
(Though all of them were blind),
That each by observation
Might satisfy his mind
— J. G. Saxe (134)
The 3rd ASM Conference on Salmonella: Biology, Patho-
genesis and Prevention took place from 5 to 9 October 2009 in
Aix-en-Provence, France. For more than 325 scientists from 43
countries, the meeting provided an opportunity to learn about
recent discoveries regarding the epidemiology, biology, and
pathogenesis of Salmonella and to identify promising new ap-
proaches for the diagnosis, treatment, and prevention of Sal-
monella infections. Jeremy Farrar, from the Oxford Clinical
Research Unit in Vietnam, compared the meeting to the pro-
verbial six blind men encountering an elephant. This proved to
be an apt characterization of a multifaceted meeting in which
Salmonella was considered from diverse perspectives. The fol-
lowing are selected highlights from oral presentations given at
the meeting, as perceived by four Infection and Immunity edi-
tors who were in attendance.
The First approached the Elephant,
And happening to fall
Against his broad and sturdy side,
At once began to bawl:
“God bless me! but the Elephant
is very like a wall!”
SALMONELLA EPIDEMIOLOGY
According to contemporary classification, the genus Salmo-
nella contains only two species, Salmonella bongori and Salmo-
nella enterica, but there are more than 2,500 serovars of S.
enterica. Although no longer prevalent in the developed world,
Salmonella enterica serovars Typhi and Paratyphi continue to
cause enteric fever in many parts of the developing world,
especially in Asia and northern regions of Africa (60, 138).
These agents are still estimated to cause approximately 22
million cases of disease and 200,000 deaths each year, primarily
in regions where sanitation is poor and clean water is inacces-
sible (37). In south Asia, approximately one of every four cases
of enteric fever is caused by Salmonella enterica serovar Para-
typhi (117), with the remainder caused by S. Typhi.
The epidemiology of Salmonella infections is changing. Jer-
emy Farrar reported a dramatic decline in the overall inci-
dence of typhoid fever in Vietnam in recent years, suggesting
that eradication of this disease might be within reach. This
reduction is not the result of a specific typhoid fever control
program but rather a consequence of economic development
and improved sanitation, paralleling the decline in typhoid
fever in the United States during the early 20th century. An
important remaining challenge for the eradication of typhoid
fever is the development and implementation of a rapid, ac-
curate, and affordable diagnostic assay that can be used in
areas of typhoid fever endemicity (84). Another problem is the
rapidly emerging antibiotic resistance among Salmonella sero-
vars responsible for typhoid fever, since initial reports in the
1970s (7). A recent survey of eight Asian countries revealed
nalidixic acid resistance in 5 to 51% of S. Typhi isolates (29),
and many nalidixic acid-resistant strains are resistant to mul-
tiple antibiotics. Isolates resistant to nalidixic acid are less
responsive to fluoroquinolone antibiotics (158). Nalidixic acid-
susceptible Salmonella isolates with reduced susceptibility to
fluoroquinolones are also increasingly being recognized (38),
and the presence of these isolates may require changes in
current clinical microbiology practices used to detect nonsus-
ceptible strains. The latter resistance pattern is caused by plas-
mid-borne qnr resistance determinants, which raise MICs for
fluoroquinolones but not nalidixic acid (68). An unexpected
recent finding is that mutations conferring antibiotic resistance
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do not necessarily appear to reduce Salmonella fitness in the
absence of antibiotic selection (124).
A joint effort between the Wellcome Trust Sanger Institute,
the Oxford University Clinical Research Unit, and Patan Hos-
pital in Kathmandu, Nepal, is applying new genetic typing
methods to Salmonella isolates from enteric fever patients, in
combination with geospatial mapping (84). By use of this tech-
nology, hot spots for S. Typhi and S. Paratyphi infection have
been identified, areas of high transmission have been localized,
and factors such as elevation, water sources, and sewage dis-
posal can be taken into account in determining transmission
patterns. The linkage of genomic typing and mapping has the
potential to change thinking about transmission patterns, im-
prove epidemiologic tracking, and help abrogate transmission
at the household level.
In sub-Saharan Africa, cases of nontyphoidal salmonellosis
(NTS), frequently complicated by bacteremia, are now more
numerous than cases of enteric fever (60). Although invasive
NTS bacteremia was first documented over 20 years ago (43),
the magnitude of this emerging problem has only belatedly
been appreciated (107). The incidence of NTS has risen in
association with predisposing infections with HIV and Plasmo-
dium falciparum (24). NTS isolates are now among the most
common blood culture isolates in many parts of Africa, com-
prising as much as 50% of cases of bacteremia (23, 60, 61). The
distribution of pediatric NTS bacteremia in African children
corresponds almost precisely to the prevalence of malaria (60),
although the reasons for this correlation are poorly under-
stood.
Genomic epidemiology using powerful sequence-based meth-
ods has permitted the characterization of emerging invasive NTS
isolates. Melita Gordon, of the University of Liverpool, has doc-
umented that in Malawi NTS isolates are the leading cause of
bacteremia in children and that 75% of these isolates are Salmo-
nella enterica serovar Typhimurium (60). During relapses, bacte-
ria are more numerous in bone marrow, suggesting a persistent
intracellular reservoir of infection (62). Robert Kingsley and
colleagues at the Sanger Institute have used subgenomic assays
and whole-genome sequencing to characterize a specific inva-
sive multidrug-resistant NTS clone designated ST313 (88),
which is now dominant in Malawi and Kenya. ST313 clusters
most closely with the host-specific S. Typhimurium strain
ST128, which causes serious systemic disease in pigeons (8).
This observation suggests that ST313 may be in the very early
stages of host adaptation (88). The presence of numerous
pseudogenes indicates that ST313 is in a state of genome
degradation, typically observed in a pathogen or endosymbiont
that has become adapted to a single host. This characteristic
has been used to distinguish the genomes of generalist and
specialized Salmonella serovars (78, 99, 100, 146, 147). It is
particularly intriguing that some of the genes lost by ST313
have been implicated in S. Typhimurium virulence or are also
missing or nonfunctional in S. Typhi, suggesting that ST313
may be in the process of evolving from an intestinal pathogen
spread by food and water to an invasive enteric fever pathogen
spread from person to person. A comparison of host-adapted
and non-host-adapted strains belonging to a single serovar
provides a unique window into very early events in the evolu-
tion of host adaptation.
Genome degradation, prophage repertoire, and differential
transcriptional regulation are each proposed to influence the
host range of individual isolates belonging to Salmonella sero-
var Typhimurium (88). Previous microarray-based studies of
pigeon-adapted S. Typhimurium have suggested that gene loss
is unlikely to be involved in the host adaptation of these strains
(8). However, more recent work has demonstrated that the
pigeon-adapted S. Typhimurium strain ST128 has 17 pseudo-
genes, while ST313, the invasive human NTS strain, has 77
pseudogenes (88), indicating that genome degradation is in
fact occurring as these isolates undergo progressive adaptation
to a particular host. The transcriptional responses to temper-
ature exhibited by host-adapted S. Typhimurium strains may
also be evolving as they adapt to hosts with different body
temperatures. These studies will lead to an improved under-
standing of the specific mechanisms that determine pathogen
host range.
The Second, feeling of the tusk,
Cried, “Ho! what have we here
So very round and smooth and sharp?
To me ’tis mighty clear
This wonder of an Elephant
Is very like a spear!”
MODULATION AND EXPLOITATION OF THE
HOST BY SALMONELLA
The host-Salmonella interaction is dominated by the broad
array of sophisticated weaponry used by Salmonella to over-
come host defenses. Much of the current research on Salmo-
nella pathogenesis focuses on understanding two important
disease manifestations in immunocompetent individuals: gas-
troenteritis, caused by nontyphoidal Salmonella serovars, and
enteric fever, caused by typhoidal Salmonella serovars.
Nontyphoidal Salmonella serovars, exemplified by classical
S. enterica serovar Typhimurium strains, cause gastroenteritis
by employing two type III secretion systems (T3SS) (13, 34,
149). The invasion-associated T3SS encoded by Salmonella
pathogenicity island 1 (SPI-1) enables S. Typhimurium to enter
the intestinal epithelium (reviewed in reference 174), while the
T3SS encoded by SPI-2 is subsequently used to promote sur-
vival within macrophages (reviewed in reference 1). The SPI-1
and SPI-2 T3SS are structurally related to the archetypal
Illustration courtesy of Patrick Lane, ScEYEnce Studios.
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flagellar T3SS, which has provided a model for understanding
the intricate process involved in the self-assembly of such com-
plex nanomachines. Kelly Hughes, from the University of
Utah, provided an update on the details of flagellar assembly,
including the discovery that proton motive force, rather than
ATP hydrolysis, is required for type III secretion (81, 122).
Invasion of epithelial cells in vivo is observed within 10 to 15
min after introduction of S. Typhimurium into the intestinal
lumen, but by 4 h after infection the majority of bacteria are
located in the lamina propria, with bacteria no longer observed
within epithelial cells by electron microscopy (132). A possible
mechanism for clearance of the organism from the gut epithe-
lium has been suggested by Leigh Knodler, of the NIAID
Rocky Mountain Laboratories. Upon Salmonella invasion of a
model polarized Caco-2 C2Bb21 epithelium, expression of
SPI-1 and flagellar genes is initially downregulated, but SPI-1
expression is detectable at later time points in a subset of
bacteria rapidly replicating in the cytosol (89). Epithelial cells
containing these flagellated bacteria are extruded from the
apical surface of the monolayer in a process reminiscent of the
exfoliating processes of effete enterocytes at the tips of small
intestinal villi. The extrusion of infected epithelial cells may
represent a novel host defense mechanism to clear invasive
microbes, although this process may also reseed the intestinal
lumen with organisms.
Direct interactions of S. Typhimurium with host cells initiate
the production of proinflammatory cytokines in tissue, which
drive a rapid recruitment of neutrophils, the pathological hall-
mark of gastroenteritis caused by nontyphoidal Salmonella
serovars. Genetic methods have been employed to identify S.
Typhimurium virulence factors contributing to inflammation in
animal models. These include flagella and the SPI-1 T3SS,
which are important during the early phase of infection (71,
137, 143, 149, 152, 164, 173), and the SPI-2 T3SS, whose
contribution becomes apparent at later time points (34, 149).
Inflammatory responses mediated by the SPI-2 T3SS require
the presence of myeloid differentiation primary response pro-
tein 88 (MyD88) (72), a host adaptor protein required for
signaling through the interleukin-1 (IL-1) receptor (112,
167), the IL-18 receptor (3), and most Toll-like receptors
(TLRs) other than TLR3 (86, 103). However, little progress in
identifying host factors important for initiating SPI-1-depen-
dent inflammatory responses in vivo has been made. Work by
Wolf-Dietrich Hardt and colleagues in Zurich, Switzerland,
suggests that the presence of multiple pathways initiating SPI-
1-dependent intestinal inflammation has masked the contribu-
tion of individual factors. S. Typhimurium secretes several
SPI-1 effector proteins involved in inducing intestinal inflam-
mation in the streptomycin-pretreated mouse model, including
SipA, SopB, SopE, and SopE2 (71). An S. Typhimurium mu-
tant expressing only SopE induces intestinal inflammation by a
mechanism dependent on caspase-1, an enzyme required for
cleaving the proforms of IL-1 and IL-18 into their active
forms. Consistent with a contribution of caspase-1 to host
responses, SopE-mediated inflammation was abrogated in
mice deficient for IL-18 or the IL-1 receptor. However, when
streptomycin-pretreated mice were infected with an S. Typhi-
murium mutant expressing both SopE and SipA, an effector
protein that induces inflammation through a different pathway,
the contribution of caspase-1 to intestinal inflammation was no
longer evident histopathologically (110). The use of bacterial
genetics to restrict the in vivo inflammatory process to single
SPI-1 effector proteins is a promising strategy to elucidate the
contribution of redundant pathways producing intestinal in-
flammation. Presentations by Beth McCormick, from the Uni-
versity of Massachusetts, and Brett Finlay, from the University
of British Columbia, underscored the involvement of common
mechanisms in Salmonella enteritis and inflammatory bowel
diseases (IBDs) (52, 101). Such work promises to have impor-
tant therapeutic implications and is discussed in greater detail
below.
After crossing the epithelial barrier, S. Typhimurium is lo-
cated predominantly within mononuclear cells (macrophages
and dendritic cells) and neutrophils in the underlying tissue
(132). The SPI-2 T3SS plays an essential role in preventing
rapid clearance from the livers and spleens of mice (74) and
from the intestinal tissues of calves (149) by promoting survival
within mononuclear phagocytes (118). In his keynote address,
David Holden, from the Imperial College London, presented
evidence to indicate contact dependence of SPI-2 T3SS func-
tion during the interaction of Salmonella with macrophages. It
was known from previous work that secretion of SseB, which is
part of the SPI-2 T3SS translocation complex in the host cell
membrane, is induced by acidic pH, while other effector pro-
teins are not efficiently secreted under these conditions (20). A
series of experiments was presented to support the hypothesis
that the neutral pH of the host cell cytosol is sensed through
the needle complex following the acid pH-dependent forma-
tion of the translocation complex (76). This is proposed to
relieve the inhibition of secretion mediated by a complex com-
posed of SsaL, SsaM, and SpiC at the base of the SPI-2 T3SS
secretion apparatus, thus allowing the translocation of effector
proteins into the host cell cytosol. These observations suggest
that a mechanism for sensing the pH difference between the
phagosome and the cytosol through the T3SS secretion chan-
nel renders the secretion of effector proteins dependent on
bacterial contact with the vacuolar membrane.
The SPI-2 effectors promote Salmonella replication within
the Salmonella-containing vacuole (SCV), stabilize the vacuo-
lar membrane, influence endocytic trafficking, and induce de-
layed host cell death, among other proposed functions (163).
Salmonella interactions with mammalian cells have been
shown to involve the pathogen-directed manipulation of host
Rho GTPases (136), but Matthias Christen, representing the
laboratory of Samuel Miller at the University of Washington,
presented an example in which RhoA actually activates a bac-
terial virulence effector. The SPI-2 effector SseJ binds to the
GTP-bound form of RhoA, stimulating its lipase activity to
facilitate Salmonella esterification of cholesterol in the SCV
membrane, an event believed to play an important role in SCV
membrane dynamics (33). This observation represents the first
known instance in which a bacterial virulence factor senses
rather than alters the signaling state of a Rho GTPase.
S. Typhi and S. Typhimurium share many of the virulence
factors important for gastroenteritis, including flagella and the
SPI-1 and SPI-2 T3SS. Nevertheless, the clinical presentation
of typhoid fever differs in several important aspects from that
of gastroenteritis. First, typhoid fever has an average incuba-
tion period of 2 weeks, compared to an incubation period for
gastroenteritis of only 12 to 72 h (119). This suggests that S.
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Typhi is able to suppress and/or avoid detection by the host
immune system early in the course of infection. Second, S.
Typhi causes a systemic infection associated with the gradual
development of mononuclear inflammatory infiltrates in the
intestine (91, 109, 116, 142), while localized S. Typhimurium
infection in immunocompetent individuals is accompanied by a
rapid recruitment of neutrophils into the intestinal mucosa (41,
102). Again, this clinical observation illustrates that S. Typhi
and S. Typhimurium differ in the ways each pathogen is viewed
by the host immune system. The different disease manifesta-
tions caused by S. Typhi and S. Typhimurium in humans must
be due to their genetic differences, and understanding these
differences has become a focus of typhoid fever research in the
postgenomic era.
One such difference is the viaB locus, which is present in S.
Typhi but absent from S. Typhimurium. The viaB locus
encodes genes for the biosynthesis (tviBCDE), export
(vexABCDE), and regulation (tviA) of the S. Typhi Vi capsular
polysaccharide (153). Andreas Ba¨umler, from the University of
California at Davis, showed that acquisition of the TviA reg-
ulatory protein by S. Typhi alters expression of flagella and the
SPI-1 T3SS in response to changes in osmolarity during the
transition from the intestinal lumen to deeper tissues (170).
Introduction of the viaB locus into S. Typhimurium reduces
the inflammatory response elicited by this pathogen in strep-
tomycin-pretreated mice; this effect is observed during the
stage of infection in which inflammation is dependent on
MyD88, but it appears to be independent of the SPI-1 T3SS
(70). Two effects of Vi capsule that might blunt inflammatory
responses are the inhibition of TLR4 recognition (168) and the
repression of flagellum expression, which reduces TLR5-me-
diated responses in tissue culture models (169). Inactivation of
flagellin genes in S. Typhimurium (fliC fljB mutant) or repres-
sion of flagellin expression by introduction of the tviA gene into
the S. Typhimurium chromosome increases bacterial dissemi-
nation to the spleen in a chicken model (14). These data
suggest that viaB provides S. Typhi with both a novel virulence
determinant (Vi) and a novel regulatory gene (tviA) that alters
the expression of virulence determinants highly conserved
within the genus Salmonella, such as flagella and SPI-1.
A cluster of toxin-like genes, termed pltA, cdtB, and pltC,
represents another genetic region that distinguishes S. Typhi
from S. Typhimurium. Jorge Gala´n, from Yale University,
demonstrated that this gene cluster encodes an A/B toxin,
designated typhoid toxin, which exhibits the enzymatic activity
of a cytolethal distending toxin (69, 141). The typhoid toxin is
delivered from intracellular bacteria through both autocrine
and paracrine pathways to neighboring host cells (54, 141). The
toxin causes DNA damage, an action predicted to preferen-
tially kill host cells undergoing rapid cell division, such as
expanding B- and-T cell populations. The lack of animal mod-
els for the human pathogen S. Typhi represents a major ob-
stacle for testing this hypothesis and for studying typhoid fever
pathogenesis in general.
Significant progress in developing a mouse model for S.
Typhi infection was presented by Stephen Libby and coworkers
from the University of Washington, the University of Massa-
chusetts, and the Jackson Labs. NOD-scid-IL2R(null) mice
were engrafted with human umbilical cord blood stem cells
(hu-SRC-SCID mice) to develop a humanized mouse model
for typhoid fever (92). Initial characterization of the model
showed that in contrast to conventional or parental unen-
grafted NOD-scid-IL2R(null) mice, hu-SRC-SCID mice be-
came highly susceptible to S. Typhi infection and developed
granulomas containing multinucleated giant cells in the spleen.
The ability of S. Typhi to cause progressive lethal infection in
hu-SRC-SCID animals indicates that human immune cells are
required for S. Typhi replication in vivo. Further development
of this model promises to accelerate future research on typhoid
fever pathogenesis.
The ability to cause systemic infection may confer a selective
advantage to S. Typhi by increasing the probability of coloni-
zation of the gallbladder, from which the organism can be
reintroduced intermittently into the intestine. Chronic carriage
is essential for pathogen persistence in small host populations
and was probably a key factor in the evolution of human-
adapted S. Typhi, particularly prior to the advent of agricul-
ture, which supported higher population densities. Chronic S.
Typhi gallbladder carriage is also of interest because it is an
important risk factor for developing gallbladder cancer (166).
John Gunn, from the Ohio State University, has performed
studies of mechanisms involved in chronic gallbladder carriage
of Salmonella (36). Since gallstones, which are composed
mainly of cholesterol, are a major risk factor for developing
chronic S. Typhi carriage, biofilm formation on this surface in
the presence of bile was studied. Biofilm formation on choles-
terol by S. Typhi and S. Typhimurium requires the production
of an O-antigen capsule, which is distinct from the Vi capsular
antigen (35). Mice fed a high-cholesterol diet develop gall-
stones and exhibit increased gallbladder colonization after S.
Typhimurium infection in comparison to controls. Biofilms can
be visualized on gallstones resected from chronic S. Typhi
carriers. Collectively, these data suggest that biofilm formation
on gallstones is a mechanism contributing to the pathogenesis
of chronic gallbladder carriage in typhoid fever.
The Third approached the animal,
And happening to take
The squirming trunk within his hands,
Thus, boldly up and spake:
“I see,” quoth he, “the Elephant
Is very like a snake!”
HOST DEFENSES AGAINST SALMONELLA INFECTION
The last decade has seen a rapid growth in our understand-
ing of innate immunity, which has provided many opportuni-
ties for looking at initial host-pathogen interactions from a new
perspective. Host responses elicited by S. Typhimurium are
stereotypic, and an analysis of their induction and outcome has
provided valuable general insights into bacterium-host inter-
actions.
The interaction of S. Typhimurium with the host immune
system is initiated by direct bacterium-host cell contact, such as
occurs in SPI-1 T3SS-mediated invasion of epithelial cells.
Alternatively, this interaction can be initiated by a mechanism
in which CD18-positive dendritic cells reach through the epi-
thelium to sample luminal contents, a pathway that is indepen-
dent of SPI-1 (151). Isabelle Hautefort, from the Institute for
Food Research, United Kingdom, presented data on dendritic
cell migration in response to inoculation of ligated murine ileal
loops with a SPI-1-deficient (invA) S. Typhimurium mutant
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strain (9, 73). Marked migration of dendritic cells into intesti-
nal villi and transmigration into the intestinal lumen were
observed after infection with an S. Typhimurium invA mutant
but not following inoculation with Escherichia coli. The den-
dritic cell migration was dependent on MyD88 and was not
observed after inoculation with Salmonella strains that were
nonmotile (fliC fljB mutant) or unable to translocate flagellin
across polarized epithelial monolayers due to a mutation inac-
tivating SPI-2. Collectively, this in vivo analysis was consistent
with the hypothesis that flagellin sensed by TLR5 on the ba-
solateral surface of the sentinel intestinal epithelial layer trig-
gers dendritic cell migration in response to S. Typhimurium
infection. For initiation of responses against microbes, macro-
phages and dendritic cells express multiple pathogen recogni-
tion receptors, including the cytosolic nucleotide-binding and
oligomerization domain (NOD)-like receptors (NLRs) and
TLRs located on the cell surface or within a vacuolar compart-
ment. A subset of NLRs can activate caspase-1 and trigger
pyroptosis, a form of programmed cell death that is accompa-
nied by proteolytic activation of IL-1 and IL-18 (reviewed in
reference 51). Brad Cookson, from the University of Washing-
ton, presented evidence that S. Typhimurium-induced pyrop-
tosis activates immune responses through two major pathways.
The first is well characterized and proceeds through the pro-
teolytic activation of IL-1 and IL-18 by caspase-1. Experi-
ments presented at the meeting provided evidence for the
existence of a second pathway involving calcium fluxes that
induce lysosomal exocytosis (19). Lysosomal exocytosis was
shown to result in the release of pathogen-associated molecu-
lar patterns along with lysosomal contents, which might further
enhance cytokine induction and contribute antimicrobial ef-
fector molecules.
The sequential evolution of the immune response to Salmo-
nella over time was reviewed by Pietro Mastroeni, from the
University of Cambridge, United Kingdom (98). Evidence for
bacterial growth and NADPH phagocyte oxidase (Nox2)-me-
diated bacterial killing was observed within the first 6 h of
infection (64). At later time points, host factors, including
natural resistance-associated macrophage protein 1 (Nramp1,
Slc11a1), gamma interferon (IFN-), tumor necrosis factor
alpha (TNF-), and inducible nitric oxide synthase (iNOS),
exhibited predominantly bacteriostatic effects on S. Typhi-
murium. New insights into the role of B cells during infection
have also been obtained. During transit between host cells, S.
Typhimurium is susceptible to antibodies. B cells further con-
tribute to immunity by producing IL-6 and IFN-, promoting
the development of antigen-specific Th17 cells and Th1 cells,
respectively. During the early phase of infection, cytokine pro-
duction by B cells is driven by innate MyD88-dependent re-
sponses, while cytokine production subsequently becomes an-
tigen dependent (12).
Two vaccines for the prevention of typhoid fever, Typhim Vi
and the live oral Ty21a strain, are currently available (reviewed
in reference 129). Calman MacLennan, from the University of
Birmingham, United Kingdom, provided an update on the
development of a new conjugate Vi vaccine that has shown in
clinical trials an efficacy superior to that of the currently li-
censed vaccine. Clinical studies point to an important role for
antibodies, complement, and phagocytes in protection against
Salmonella infections (59), while T cells have a critical role in
bacterial clearance. These insights will help to guide future
vaccine development.
The Fourth reached out an eager hand,
And felt about the knee.
“What most this wondrous beast is like
Is mighty plain,” quoth he;
“Tis clear enough the Elephant
Is very like a tree!”
CHALLENGE OF FOOD-BORNE NONTYPHOIDAL
SALMONELLOSIS
Since national surveillance of NTS in the United States was
established by the Centers for Disease Control (CDC) in 1963,
the incidence of these infections has made a steady ascent,
reaching a plateau at 14 to 15 cases per population of 100,000
during the last 20 years despite strong efforts to reduce these
numbers (157). At the beginning of the last decade, the CDC
set a national goal to reduce NTS cases by 50%, to 6.8 culture-
confirmed cases per population of 100,000 by 2010 (157). Of
the common food-borne pathogens, Salmonella is presently the
furthest from its national health target. Salmonella serovars
Typhimurium and Enteritidis are most prevalent in the United
States, with each currently responsible for 16 to 17% of cases.
However, several other serovars, including Newport, Javiana,
and the Salmonella I 4,[5],12:1: variant, are in ascendance
(145, 157). In recent years, multistate outbreaks of NTS from
conventional sources, such as raw meats, and unconventional
food sources not previously known to transmit Salmonella have
required increased active epidemiologic surveillance and cre-
ated new challenges in tracing and controlling these outbreaks.
Robert Tauxe, of the Centers for Disease Control, discussed
recent food-borne outbreaks of NTS in the United States, with
the recognition of new food vectors, including peanut butter, a
vegetarian snack food, dry dog food, dry puffed breakfast ce-
real, microwaveable pot pies, and hot peppers (145). Salmo-
nella contamination of a peanut paste used as a basic ingredi-
ent in many processed foods led to the recall of 3,900 products.
Factors contributing to the increasing frequency of NTS in-
clude gaps in systems to ensure food safety, a limited under-
standing of the ecological determinants of Salmonella contam-
ination of foods in the field, and improved methods for active
surveillance. In the United States, active surveillance for Sal-
monella and other food-borne pathogens is conducted by the
Food-borne Active Disease Surveillance Network (FoodNet),
established in 1995 as a component of the CDC’s Emerging In-
fections Program (EIP). FoodNet is a collaborative effort of mul-
tiple federal agencies, including the CDC, the USDA, the FDA,
and 10 cooperating EIP sites (http://www.cdc.gov/FoodNet
/surveillance_pages/whatisfoodnet.htm), that now covers 15.1%
of the U.S. population.
The investigation of large food-borne NTS outbreaks and
international typhoid fever outbreaks in recent years has re-
quired improved epidemiologic, tracking, and typing methods
to identify the sources. Although serotyping remains com-
monly in use for typing and tracking of isolates, more precise
molecular methods are being employed to determine whether
isolates from multiple, even widely dispersed, cases of salmo-
nellosis are related. In the United States, pulsed-field gel elec-
trophoresis (PFGE) data on NTS isolates is collected and
made accessible via PulseNet, a nationwide system used to
2360 MINIREVIEW INFECT. IMMUN.
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
subtype bacteria that cause food-borne disease, with participa-
tion from a network of state and local health departments and
federal agencies. PulseNet has become an essential tool for
linking cases caused by single bacterial strains and following
the spread of large outbreaks (145).
Additional typing methods include multilocus sequence typing
(MLST) and MLST-like approaches (see the S. enterica MLST
database at http://mlst.ucc.ie/mlst/dbs/Senterica) (87) and newer
approaches that use single nucleotide polymorphisms (SNPs) to
determine the haplotypes of disease isolates. MLST has been
used by Gabriel Perron, Sylvain Quessy, and colleagues at McGill
University and the Universite´ de Montre´al to analyze reservoirs
of antibiotic-resistant bacteria in asymptomatic Canadian live-
stock (123). MLST-like approaches include multi-virulence-locus
sequence typing (MVLST) (31, 32), a method that combines
traditional MLST with typing of conserved virulence loci and has
recently been used to assess the stability of structural genes en-
coded on SPI-1 (25).
Strains belonging to some Salmonella serovars, such as S.
Typhi, are too closely related to differentiate using traditional
typing methods (77, 130). For such strains, complete genome
sequencing can reveal SNPs throughout the genome (77). In the
case of S. Typhi, complete genome sequencing using both Roche
454 and Illumina Solexa sequencing technology allowed Kathryn
Holt and colleagues at the Wellcome Trust Sanger Institute
(Cambridge, United Kingdom) to identify 2,000 SNPs (77). Ge-
nome-wide SNP typing is now being used by these investigators to
determine the haplotypes of 260 S. Typhi isolates collected in
Vietnam over a 2-year period (79). Although 98% of these iso-
lates consisted of a single haplotype, 40 SNPs allowed differenti-
ation of isolates within this group. Combining genome-wide SNP
typing and geospatial mapping technology allows the discrimina-
tion of isolates down to the household level, providing clues about
transmission into and within a given household (79). While SNP
typing is not yet used to analyze NTS outbreaks, it will potentially
be very useful for this purpose as well.
Following, tracing, and controlling Salmonella outbreaks
that result from NTS contamination of traditional and nontra-
ditional foods are major challenges for food safety. Although
61% of U.S. Salmonella infections in 2008 were caused by
contamination of foods that are not traditional vectors for this
organism (145), knowledge of how Salmonella contaminates,
survives, and grows on foods, including vegetables and plants,
remains rudimentary. Jeri Barak and colleagues at the Univer-
sity of Wisconsin have begun to determine the mechanisms
used by Salmonella to colonize plants (11). A Salmonella en-
terica serovar Newport Tn10 mutant library was screened for
defects in attachment to alfalfa sprouts. Many unique mutants
were obtained, and 65% of the transposon insertions associ-
ated with reduced attachment were in genes of unknown func-
tion (“FUN genes”). Transposon insertions in genes encoding
curli fimbriae, cellulose metabolism, and O-antigen synthesis
were also isolated. Mutations affecting curli and cellulose were
complemented with restoration of a wild-type phenotype. Mu-
tations in two FUN genes, STM0278 and STM0650, were
found to confer defects in swarming motility that are reversed
in the presence of polysaccharide-rich root exudates. Further
study of Salmonella colonization of plants, fruits, and vegeta-
bles may lead to new strategies to prevent contamination of
important food sources.
Contaminated meat and poultry products, the traditional
sources of NTS in humans, continue to be problematic, but
knowledge of the factors required for NTS colonization of
livestock is rapidly expanding. Recent efforts have identified
Salmonella genes required for colonization of various livestock
hosts, including cattle, chickens, and swine (28, 80, 90, 105).
Using signature-tagged mutagenesis and other techniques,
these studies have generated extensive lists of candidate genes
implicated in the colonization of multiple or single hosts. Eir-
wen Morgan and colleagues in the United Kingdom have ap-
plied a new technique called transposon-mediated differential
hybridization (TMDH) (30) to interrogate pools of transposon
mutants to identify S. Typhimurium genes required during
infection in different livestock models (106). In TMDH, trans-
poson locations are easily mapped using a custom tiling array.
This and similar new technologies should allow the compre-
hensive identification of Salmonella genes necessary for colo-
nization of livestock hosts, which in turn may lead to improved
preharvest interventions to prevent Salmonella transmission.
The Fifth, who chanced to touch the ear,
Said: “E’en the blindest man
Can tell what this resembles most,
Deny the fact who can
This marvel of an Elephant
Is very like a fan!”
NEW GENE REGULATORY PARADIGMS
IN SALMONELLA
In the course of infection, Salmonella must adapt to diverse
environments. These range from an external environment,
such as a contaminated food or water source, to the acidic
stomach lumen of the host, the intestinal tract (including the
microenvironment of the surface epithelium), and the dynamic
intracellular confines of the macrophage vacuole, as well as
various extraintestinal tissues (e.g., liver and spleen). The reg-
ulation of Salmonella gene expression in response to environ-
mental and stress conditions plays a critical role in the ability
to cause disease. Numerous virulence genes, many of which are
situated together in groups called pathogenicity islands, are
required for one or more steps in the infection process.
The Salmonella pathogenicity islands were acquired by hori-
zontal gene transfer. However, the mechanisms by which newly
acquired genes become integrated into the regulatory networks of
a recipient cell without compromising competitive fitness are
poorly understood. Importing even a structurally simple plasmid
can impose a fitness cost on a bacterium (reviewed in reference
46). An emerging paradigm proposes that the global nucleoid-
associated regulatory protein called H-NS facilitates the acquisi-
tion of horizontally transferred DNA by binding to AT-rich se-
quences and silencing their expression (44, 45, 96, 114, 115).
H-NS is a small, abundant protein that forms dimers with the
ability to create DNA-protein-DNA bridges (39). In addition,
H-NS is capable of cooperative binding interactions with high-
affinity sites (22). H-NS-containing nucleoprotein structures im-
pede the movement of RNA polymerase, thereby repressing gene
transcription. It is uncertain whether DNA bridging is sufficient to
account for transcriptional silencing or whether higher-order nu-
cleoprotein complexes are required (48).
The DNA binding preference of H-NS correlates with se-
quences that exhibit intrinsic curvature (40, 126, 148). Recent
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studies have determined that H-NS binding occurs at AT-rich
regions throughout the S. Typhimurium genome, including
major virulence genes located on the virulence plasmid or
within Salmonella pathogenicity islands (96, 115). AT-rich re-
gions can form nucleation sites from which the H-NS protein
can spread laterally along DNA, forming nucleoprotein fila-
ments in addition to DNA bridges. Curvature can also facili-
tate bridge formation and is responsive to environmental
parameters, such as temperature and osmolarity (126). Tran-
scriptional silencing of foreign DNA by H-NS, referred to as
“xenogeneic silencing” (114), helps to explain why horizontally
transferred DNA is AT rich relative to the resident genome,
i.e., because recognition by H-NS facilitates the integration of
this DNA into existing regulatory networks. A variety of mech-
anisms can counter transcriptional silencing by H-NS to allow
gene expression under selected conditions (114, 144).
A protein related to H-NS, called Sfh, is encoded by R27
and related self-transmissible plasmids carried by some Sal-
monella strains (47). Sfh can fully substitute for H-NS (and
vice versa) in Escherichia coli and Shigella flexneri and has a
similar preference for binding curved AT-rich DNA se-
quences (16, 42). Charles Dorman, from Trinity College
Dublin, described sfh as a “stealth gene” that enables the
AT-rich pSf-R27 plasmid to enter new bacterial hosts with a
minimal impact on global gene expression patterns and fit-
ness, which maintains the competitive fitness of the new
plasmid-host combination (47). This has the effect of stabi-
lizing the horizontal transmission of genetic information
within and between bacterial populations, as corroborated
by the presence of hns-like genes on other plasmids (17, 47,
53) as well as other horizontally acquired AT-rich DNA
elements, such as bacteriophages and pathogenicity islands,
that are known to bind H-NS (17, 27, 94).
Although Salmonella enterica and Escherichia coli are often
regarded as close relatives, Patrick Higgins, from the University of
Alabama, has obtained surprising evidence of major differences in
the superhelicities and hence the chromosomal dynamics of these
two species (75). The higher average supercoiling density of mid-
log-phase E. coli than of Salmonella can account for the toxicity of
the Salmonella GyrB protein for E. coli, as well as a variety of
other important biological characteristics, including a greater re-
ceptivity of Salmonella to foreign DNA.
Two-component regulatory systems also coordinate gene ex-
pression in response to specific environmental signals and rep-
resent the major paradigm for signal transduction in bacteria.
Two-component systems conventionally contain a sensor ki-
nase (often a membrane protein that functions in trans-mem-
brane signaling) and a response regulator (typically a DNA-
binding protein that initiates transcription). For example, in S.
enterica the SsrA/SsrB two-component system regulates the
expression of SPI-2 genes. Specifically, the SsrB protein binds
to the promoters of all SPI-2 functional gene clusters (159) and
is essential for expression of the SPI-2 T3SS and its effectors
(171). Recent observations suggest that SsrB functions both by
activating gene transcription and by antagonizing H-NS-medi-
ated silencing. Indeed, the locations of SsrB binding sites,
which include sites upstream of, overlapping with, or down-
stream of transcriptional start sites, are not consistent with a
classical mechanism of transcriptional activation (159). Fur-
thermore, it has been shown that SPI-2 expression no longer
displays an absolute requirement for SsrB in an hns mutant
background (159). Linda Kenney, from the University of Illi-
nois at Chicago, has posed the question of how SsrB relieves
H-NS silencing. Using atomic-force microscopy and single-
molecule experiments, she has examined H-NS–DNA interac-
tions and the effects of SsrB on H-NS/DNA binding (95). This
study has revealed the two binding modes of H-NS. At high
magnesium concentrations DNA bridging is observed, whereas at
lower magnesium concentrations H-NS polymerization results in
elongation and stiffening of the nucleoprotein complex. SsrB re-
lieves H-NS binding only at the lower magnesium concentrations,
suggesting that H-NS polymerization and the formation of
higher-order nucleoprotein complexes are responsible for tran-
scriptional silencing, which can be relieved by competition with a
high-affinity DNA-binding protein (e.g., SsrB).
The PhoQ/PhoP two-component regulatory system is an-
other major regulator of Salmonella virulence (67). The PhoP
regulatory protein governs virulence and adaptation to the
intraphagosomal environment, and its activity is controlled by
the sensor protein PhoQ, which is responsive to antimicrobial
peptides, acid pH, and low Mg2 concentrations (127). In S.
Typhimurium, PhoP affects the expression of as many as 3% of
all Salmonella genes (85). Genes directly controlled by the
PhoP protein often differ in their promoter structures, result-
ing in distinct expression levels and kinetics in response to the
inducing signal. Such differential expression of PhoP-activated
genes requires a fine adjustment in the levels of active PhoP
protein as well as differences in the cis-acting promoters of
genes directly under PhoP control. Eduardo Groisman, from
Washington University in St. Louis, presented a series of studies
to demonstrate that the order of PhoP-activated gene expression
is not directly correlated with the RNA level or with the amount
of active PhoP protein present (66). Ancestral PhoP-activated
genes are transcribed before horizontally acquired genes. The
sequential expression appears to be a consequence of H-NS si-
lencing, which must be countered by the PhoP-activated regulator
SlyA (93) in order for the horizontally acquired genes to be
transcribed, resulting in their delayed expression.
Gene expression of virulence proteins can also be regulated
posttranscriptionally. In S. Typhimurium, RNA-mediated reg-
ulation occurs as a consequence of small RNAs (sRNAs; non-
coding RNAs) that act as posttranscriptional regulators of
gene expression. Bacterial sRNAs are typically 50 to 250 nu-
cleotides in length and are commonly untranslated and en-
coded within intergenic regions of bacterial chromosomes
(155). The synthesis of sRNAs is tightly regulated and often
induced by a specific stress- or virulence-related condition.
Most sRNAs function as regulators by base paring with trans-
encoded mRNAs, consequently repressing or activating target
gene expression at a posttranscriptional level (154). The stron-
gest evidence that sRNAs serve important functions in Salmo-
nella is based on studies with Hfq (154), a protein that prefer-
entially binds A/U-rich, single-stranded regions of RNA and is
required for both intercellular stability of many regulatory
rRNAs and annealing with target mRNAs (150). The numbers
of phenotypes and deregulated genes observed in a Salmonella
hfq deletion mutant surpass those reported for any other
pathogen (139, 154). Recent studies have determined that that
an hfq mutation attenuates the ability of Salmonella to invade
epithelial cells, secrete virulence factors, infect mice, and sur-
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vive inside macrophages (140). Moreover, transcriptome anal-
ysis has revealed that Hfq controls the expression of nearly
20% of Salmonella genes, including genes in several horizon-
tally acquired pathogenicity islands (SPI-1, -2, -3, -4, and -5),
two sigma factor regulons, and the flagellar gene cascade (139).
Since Hfq acts in concert with sRNAs, it is inferred that many
of the above-described phenotypes are attributable to the loss
of gene regulation by Hfq-associated sRNAs. Jo¨rg Vogel, from
the Max Planck Institute in Berlin, Germany, has used deep
sequencing and sRNA pulse expression coupled with global
transcription profiling to determine that several hundred Sal-
monella mRNAs may be controlled directly by Hfq-dependent
small RNAs. Both conserved and Salmonella-specific sRNAs
are recruited to appropriately transmit information from the
Salmonella core genome and virulence regions at a posttran-
scriptional level (156). Nine Salmonella-specific sRNAs that bind
to Hfq have been identified thus far, and the sgrS sRNA (induced
by glucose phosphate stress) has been found to contain a con-
served antisense domain that targets both ptsG and sopD mRNA.
Yet another regulatory paradigm is provided by small hy-
drophobic peptides that interact with protein partners at the
inner membrane to modulate protein activity and/or stability
(6). The control of protein stability allows a bacterial cell to
adjust to changing conditions by adjusting the rate of protein
turnover. Regulated proteolysis has been well characterized
for a few proteins, including proteins involved in stress re-
sponses (63). Anne-Be´atrice Blanc-Potard and Eric Alix, at
CNRS in Montpellier, France, have recently identified a reg-
ulatory hydrophobic peptide called MgtR, which is encoded by
a nonannotated gene in the mgtCB operon (5). MgtR interacts
with MgtC in vivo and promotes the degradation of MgtC by
the FtsH protease, which belongs to a family of ATP-depen-
dent AAA proteases whose substrate recognition is regulated
by adaptor proteins (130). The mgtR gene is cotranscribed with
mgtC, which encodes a virulence factor important for intra-
macrophage survival (4). The transmembrane segment of
MgtR interacts with MgtC in a bacterial two-hybrid system
(83), suggesting that this interaction might unfold MgtC to
render the protein susceptible to FtsH-mediated degradation.
This provides the first example of an alpha-helical hydrophobic
peptide that modulates degradation of a membrane protein by
an AAA protease. A genome-wide analysis has recently iden-
tified 14 new putative membrane peptides, including peptides
with homologs in E. coli and peptides specific to Salmonella,
like MgtR (21). It is envisaged that the discovery of this novel
class of molecules will lead to new insight regarding the inter-
actions between alpha-helices within the biological membrane.
The Sixth no sooner had begun
About the beast to grope,
Than, seizing on the swinging tail
That fell within his scope,
“I see,” quoth he, “the Elephant
Is very like a rope!”
BROAD BIOLOGICAL IMPLICATIONS OF
SALMONELLA RESEARCH
Studies of Salmonella genetics and physiology have helped
to form the foundation of modern molecular biology. Similarly,
investigation of the molecular and cellular mechanisms that
underlie S. Typhimurium pathogenesis has provided new in-
sights and practical applications that are broadly relevant to
infectious diseases and even to a variety of noninfectious con-
ditions, such as inflammatory bowel disease, hemochromatosis,
and atherosclerosis.
Inflammatory bowel disease. The IBDs Crohn’s disease
(CD) and ulcerative colitis (UC) are lifelong, relapsing ill-
nesses that affect the gastrointestinal tract primarily in young
adults. Such conditions are characterized by chronic inflamma-
tion, mucosal damage, and epithelial cell destruction resulting
from a complex interplay of genetic, immunologic, and micro-
bial factors. The active phase of IBD is histologically charac-
terized by a pronounced infiltration of neutrophils (polymor-
phonuclear leukocytes [PMNs]) into and across the epithelial
lining of the intestine, accompanied by epithelial cell necrosis
and ulceration (120, 121, 172). Disease activity and symptom-
atology correlate with the presence of these findings (120, 172).
Remarkably, a similar massive transepithelial migration of
PMNs occurs in the acute phase of gastroenteritis induced by
S. Typhimurium (41, 102, 131). Thus, insight into pathogen-
elicited acute inflammation of the intestine may serve as a
model for the biological events that evoke active inflammation
in IBD. Recently, it was discovered that the eicosanoid hep-
oxilin A3 (HXA3) is responsible for directing the transepithe-
lial migration of neutrophils associated with intestinal inflam-
mation (108). Beth McCormick, from the University of
Massachusetts Medical School, has used Salmonella-infected
polarized intestinal cell monolayers to demonstrate a novel
mechanism for the vectored secretion of HXA3 from the apical
surfaces of epithelial cells, involving the ATP binding cassette
(ABC) transporter multidrug resistance-associated protein 2
(MRP2). Multiple in vitro and in vivo models of S. Typhi-
murium infection have demonstrated that induction of intes-
tinal inflammation profoundly upregulates apical expression of
MRP2 and that interference with HXA3 synthesis and/or
MRP2 function markedly reduces inflammation and the sever-
ity of disease. Inflamed intestinal epithelia in human biopsy
specimens also exhibit upregulation of MRP2. These findings
not only shed new light on the contribution of ABC transport-
ers to the pathogenesis of S. Typhimurium enteritis but also
identify novel targets for the treatment of epithelium-associ-
ated inflammatory conditions, such as IBD.
Although inflammatory changes in intestinal physiology
cause many of the symptoms associated with CD, significant
morbidity also results from the irreversible tissue injury and
fibrosis that frequently occur as a complication (2, 15). Al-
though more than one-third of patients with CD develop a
distinct fibrostenosing phenotype that results in recurrent in-
testinal stricture formation, good models that mimic the pa-
thology of intestinal fibrosis have been lacking (26). Fibrosis in
CD is believed to result from an overzealous healing response
to injury (128). For reasons that remain unclear, the reparative
process associated with CD progresses uncontrollably, leading
to the proliferation of mesenchymal cells and the unrestrained
deposition of the extracellular matrix (ECM) (57). Abnormal
contraction of the ECM leads to scar formation and tissue
distortion. Ultimately, this fibrotic process thickens the wall of
the gut, reducing flexibility and narrowing the bowel lumen,
resulting in obstructive strictures (10, 57).
Brett Finlay, from the University of British Columbia, has
developed a mouse model of chronic colitis and intestinal
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fibrosis that mimics many of the features of CD-induced fibro-
sis (52). This model is unique in that the intestinal fibrosis is
initiated by S. Typhimurium infection. In this model, mice are
pretreated with streptomycin prior to oral infection with S.
Typhimurium, and the resulting enteric phase of infection
leads to heavy colonization of the cecum and colon, with the
development of significant colitis (65). Initial characterization
of the model demonstrated that factors contributing to fibrosis
are similar to those implicated in cecal inflammation in the
streptomycin-pretreated mouse model, including the flagellar,
SPI-1, and SPI-2 T3SS on the bacterial side (13, 34, 143) and
Th1 cytokines, Th17 cytokines, and T cells on the host side
(58). This model highlights two important advances in the
study of intestinal fibrosis: (i) infection with S. Typhimurium
leads to chronic infection and colitis in association with exten-
sive transmural ECM deposition within the cecum and colon,
and (ii) fibrosis and extensive transmural inflammation occur
along the entire length of the colon, with the most severe and
extensive fibrosis found in the cecum. With such consistent
localization of fibrotic areas, it is hoped that this model may
serve to aid the future investigation of mechanisms underlying
the fibrotic response.
Hemochromatosis. Iron plays important roles in both patho-
gen virulence and host innate immunity (82, 135). Alterations
of iron homeostasis in humans affect susceptibility to infectious
disease. For example, iron overload from dietary sources, he-
molysis, or inherited metabolic disorders enhances susceptibil-
ity to salmonellosis, tuberculosis, and other infections (55, 97,
111, 160). Infection and other inflammatory stimuli induce an
“iron-withholding response” in the host that reduces the avail-
ability of iron within the host environment and constitutes an
important component of innate immunity (56). Hereditary
hemochromatosis (HH) is a group of genetic disorders char-
acterized by an abnormal accumulation of iron in tissues (125).
The most common form of the disease (type I) is caused by
variations in HFE, the hemochromatosis gene, which encodes
a nonclassical major histocompatibility complex class I-like
protein (50). The HFE protein forms a complex with the trans-
ferrin receptor and regulates multiple aspects of cellular iron
homeostasis (50, 125, 165, 175). Two missense mutations in
HFE (C282Y and H63D) account for most cases of HH.
Recent studies with S. Typhimurium have revealed a novel
role for iron in the regulation of the inflammatory response
(161). The mouse model of type I hemochromatosis is associ-
ated with an attenuated inflammatory response to Salmonella
infection, both in vivo and in cultured macrophages. HFE
mutations also confer increased resistance against intracellular
pathogens that require iron, and Manfred Nairz, of the Med-
ical University in Innsbruck, Austria, presented data to suggest
a mechanistic basis for this observation (113). He showed that
mice lacking one or both HFE alleles are not only protected
from S. Typhimurium septicemia but also exhibit increased
survival, suggesting that HFE-deficient mice are more resistant
to infection. This finding was associated with increased pro-
duction of the enterochelin-binding peptide lipocalin-2 (Lcn2),
which promotes iron efflux and reduces the availability of iron
for Salmonella within HFE-deficient macrophages (113). In
contrast, Hfe/ Lcn2/ macrophages are unable to withhold
iron from intracellular Salmonella, and as a consequence bac-
terial proliferation is unrestrained. Thus, although individuals
with hereditary hemochromatosis suffer consequences from
iron overload in tissues, the iron content of their macrophages
is actually reduced, limiting the growth of intracellular Salmo-
nella. The evolutionary benefit provided by reduced inflamma-
tory responses and enhanced resistance to intracellular patho-
gens may account for the high prevalence of hemochromatosis
as a genetic disorder; this idea has been used to explain the
unusually high frequency of the HFE gene variants in Euro-
pean populations (104).
Atherosclerosis and other inflammatory disorders. Diverse
conditions, including atherosclerosis, cerebral ischemia, in-
flammatory bowel disease, and neurodegenerative disorders,
exhibit the common denominators of caspase-1 activation, in-
flammation, and cell death (reviewed in references 18 and 51).
Caspase-1-dependent programmed cell death, referred to as
“pyroptosis,” can be stimulated by a range of microbial patho-
gens, including Salmonella, Francisella, and Legionella (18).
Pyroptosis is morphologically and mechanistically distinct from
other forms of cell death, and caspase-1 dependence is a de-
fining feature of pyroptosis. Specifically, pyroptosis features
rapid plasma membrane rupture and the activation and release
of the proinflammatory mediators IL-1 and IL-18 (18).
Pyroptosis protects the host against infection but can also result in
pathological inflammation. Brad Cookson, from the University of
Washington, suggests that a fine balance must be achieved to
utilize pyroptosis as a protective host response to infection while
avoiding detrimental consequences of caspase-1 activation (19).
For example, mutations in Nod-like receptor (NLR) proteins
lead to aberrant caspase-1 activation, which is associated with
hereditary autoinflammatory syndromes (18). Caspase-1 defi-
ciency or pharmacological inhibition may provide protection
against inflammation, cell death, and subsequent organ dys-
function, making caspase-1 an attractive therapeutic target in
both infectious and noninfectious inflammatory conditions.
Notably, the protection afforded by caspase-1 deficiency
against sepsis and renal failure is not mimicked by neutraliza-
tion of the cytokines IL-1 and IL-18 (49, 133, 162), indicating
that caspase-1 has important roles in inflammation in addition
to cytokine processing. The conserved proinflammatory pro-
grammed cell death pathway of pyroptosis, elucidated by stud-
ies with Salmonella, is clearly of broad biological significance.
And so these men of Indostan
Disputed loud and long,
Each in his own opinion
Exceeding stiff and strong,
Though each was partly in the right,
And all were in the wrong!
So oft in theologic wars,
The disputants, I ween,
Rail on in utter ignorance
Of what each other mean,
And prate about an Elephant
Not one of them has seen
Despite many advances in Salmonella research, Salmonella
infections continue to cause substantial morbidity and mortal-
ity throughout the world. Food-borne outbreaks occur with
regularity, enteric fever continues as a major public health
problem in many parts of the world, multiple Salmonella sero-
vars are responsible for major economic losses in livestock, and
nontyphoid Salmonella has emerged as a highly invasive patho-
gen in sub-Saharan Africa. The challenge is to apply the ever-
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increasing understanding of Salmonella to reduce its burden on
human society. Recent discoveries have not only moved the
Salmonella field closer to this goal but have also led to the
creation of novel biological paradigms and therapeutic ap-
proaches with far-reaching applications. Salmonella research-
ers may no longer be working blind, but much work remains
before this elephant can be tamed.
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